These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


257 related items for PubMed ID: 14587200

  • 1. [Dual platelet inhibition with clopidogrel and ASS. Who profits from the combination?].
    MMW Fortschr Med; 2003 Jul 10; 145(27-28):64. PubMed ID: 14587200
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [New guidelines in acute coronary syndrome. Clopidogrel for nine months is recommended].
    MMW Fortschr Med; 2002 Oct 03; 144(40):47. PubMed ID: 12440296
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel.
    Prescrire Int; 2009 Oct 03; 18(103):193-5. PubMed ID: 19877380
    [Abstract] [Full Text] [Related]

  • 7. Antiplatelet drugs for patients at high cardiovascular risk. Aspirin generally remains the best choice.
    Prescrire Int; 2009 Dec 03; 18(104):272-3. PubMed ID: 20027714
    [No Abstract] [Full Text] [Related]

  • 8. [Clopidogrel protection is not increased further by ASS!].
    Bogousslavsky J.
    Praxis (Bern 1994); 2004 Aug 25; 93(35):1390. PubMed ID: 15468578
    [No Abstract] [Full Text] [Related]

  • 9. [Clearly superior in acute coronary syndrome. Helps aggressive platelet inhibition even after stroke?].
    MMW Fortschr Med; 2003 Mar 06; 145(10):57. PubMed ID: 12688032
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [New US guidelines. Myocardial infarct is now treated more aggressively].
    MMW Fortschr Med; 2002 May 16; 144(20):64. PubMed ID: 12119892
    [No Abstract] [Full Text] [Related]

  • 12. [Combination is standard. Dual thrombocyte function inhibition in acute coronary syndrome].
    MMW Fortschr Med; 2004 May 16; 146 Suppl 1():8-9. PubMed ID: 15493411
    [No Abstract] [Full Text] [Related]

  • 13. Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial.
    Bhatt DL, Flather MD, Hacke W, Berger PB, Black HR, Boden WE, Cacoub P, Cohen EA, Creager MA, Easton JD, Hamm CW, Hankey GJ, Johnston SC, Mak KH, Mas JL, Montalescot G, Pearson TA, Steg PG, Steinhubl SR, Weber MA, Fabry-Ribaudo L, Hu T, Topol EJ, Fox KA, CHARISMA Investigators.
    J Am Coll Cardiol; 2007 May 15; 49(19):1982-8. PubMed ID: 17498584
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Combined antithrombotic therapy for acute coronary syndrome.
    Gawaz M, Müller I, Besta F.
    Semin Vasc Med; 2003 May 15; 3(2):163-76. PubMed ID: 15199479
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Potent low dose platelet inhibitory effects of clopidogrel and aspirin on coronary thrombus formation in an animal model of acute unstable angina.
    Bierbach B, Horstick G, Berg O, Heimann A, Münzel T, Vahl CF, Kempski O, Darius H.
    Thromb Haemost; 2006 Feb 15; 95(2):354-61. PubMed ID: 16502561
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Randomized comparison of the effects of ASA plus clopidogrel versus ASA alone on early platelet activation in acute coronary syndromes with elevated high-sensitivity C-reactive protein and soluble CD40 ligand levels.
    Vavuranakis M, Latsios G, Aggelis D, Bosinakou I, Karambelas I, Tousoulis D, Toutouzas K, Stefanadis C.
    Clin Ther; 2006 Jun 15; 28(6):860-71. PubMed ID: 16860169
    [Abstract] [Full Text] [Related]

  • 20. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial.
    Fox KA, Mehta SR, Peters R, Zhao F, Lakkis N, Gersh BJ, Yusuf S, Clopidogrel in Unstable angina to prevent Recurrent ischemic Events Trial.
    Circulation; 2004 Sep 07; 110(10):1202-8. PubMed ID: 15313956
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.